Growing revenues put Creso Pharma in box seat to capitalise on positive cannabis momentum Listed cannabis company Creso Pharma Ltd. (ASX: CPH) looks to have started 2021 as it finished…
ASX cannabis stocks are gaining momentum, stimulated by significant developments in the global regulatory environments in recent months. On the cusp of a potential rerate is $29M capped Neurotech International…
The prices of precious metals (gold and silver) have experienced a slight pull back in recent months. For many, particularly leveraged early stage stocks, this suggests a likely return to…
Minbos Resources Limited (ASX: MNB) last week announced a Memorandum of Understanding (MOU) with the International Fertilizer Development Centre (IDFC), which will work to develop and grow the Small Holder…
Last week, Creso Pharma Limited’s (ASX:CPH; FRA: 1X8) wholly-owned Canadian cannabis cultivation subsidiary, Mernova Medicinal Inc. received three purchase orders with a combined value of C$275,023 (A$288,159). These new purchase…
